Hematuria. Recurrent and persistent hematuria
Conditions
Interventions
Intervention 1: Intervention group: In the operating room, 15 minutes before the operation, 10 cc of 2% colorless lidocaine gel (Sinadaro Pharmaceutical Company, Iran) is injected into the urethra and
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Candidate for rigid cystoscopy Diagnosis of lower urinary tract symptoms including irritative symptoms (urinary urgency, frequency, and Bedwetting) and obstructive symptoms (weak urine stream, incomplete bladder emptying, straining to start urination, and intermittent urinary retention) Age between 35 and 75 years Hematuria
Exclusion criteria
Exclusion criteria: Unwillingness to participate in the study History of allergy to any of the medications lidocaine and benzocaine Concomitant use of painkillers in the last 24 hours Liver disease Renal failure History of neuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: During and 5 minutes after rigid cystoscopy. Method of measurement: Visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of pain relief. Timepoint: During and 5 minutes after cystoscopy. Method of measurement: Visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Morteza Nasiri
Babol University of Medical Sciences
Outcome results
None listed